BC12200 THERAPEUTIC MECHANISM OF BET BROMODOMAIN INHIBITOR IN BREAST CANCER

$654,320FY2013Department of DefenseDOD

Dana-Farber Cancer Institute, Inc.

Investigators

View source on USAspending →